WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 1065

Legislative bill overview

HB 1065 establishes a cancer clinical trial program in Indiana designed to improve access to experimental cancer treatments and research participation. The bill creates a framework for coordinating clinical trials, potentially increasing patient opportunities to participate in cutting-edge cancer research and treatment options.

Why is this important

Cancer patients often face limited treatment options, and clinical trials provide access to innovative therapies not yet widely available. By formalizing a clinical trial program, Indiana aims to connect patients with research opportunities while potentially advancing cancer treatment knowledge and improving outcomes for both current and future patients.

Potential points of contention

  • Funding and implementation costs: Establishing and maintaining a clinical trial coordination program requires sustained state resources, and the bill's funding mechanism may be subject to budget scrutiny
  • Equitable access concerns: Questions about whether the program ensures fair access across geographic regions and socioeconomic groups, or if it primarily benefits patients near major medical centers
  • Regulatory oversight: Balancing streamlined patient participation with adequate safety protocols and informed consent procedures, particularly regarding vulnerable populations with serious diagnoses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.